Kitov Pharmaceuticals Holdings PE Ratio 2014-2018 | KTOV

Current and historical p/e ratio for Kitov Pharmaceuticals Holdings (KTOV) from 2014 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Kitov Pharmaceuticals Holdings PE ratio as of December 14, 2018 is 0.00.
Kitov Pharmaceuticals Holdings PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2018-12-14 0.92 inf
2018-06-30 2.64 0 0.00
2017-12-31 2.28 0 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.014B $0.000B
Kitov Pharmaceuticals Holdings Ltd. is a pharmaceutical company which focused on the development of therapeutic candidates. The company's product candidate consists of KIT-302, is formulated for treatment of pain caused by osteoarthritis and hypertension, which can be pre-existing or caused by the treatment for OA. Kitov Pharmaceuticals Holdings Ltd. is based in Jerusalem, Israel.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $53.409B 11.39
Zoetis (ZTS) United States $42.496B 29.10
Grifols (GRFS) Spain $12.892B 15.73
Jazz Pharmaceuticals (JAZZ) Ireland $8.479B 12.17
Ionis Pharmaceuticals (IONS) United States $7.282B 0.00
Tilray (TLRY) United States $6.999B 0.00
Neurocrine Biosciences (NBIX) United States $6.469B 1426.80
Nektar Therapeutics (NKTR) United States $6.319B 9.06
Catalent (CTLT) United States $5.036B 21.12
Impax Laboratories (AMRX) United States $4.810B 25.57
Sage Therapeutics (SAGE) United States $4.782B 0.00
United Therapeutics (UTHR) United States $4.703B 7.69
Loxo Oncology (LOXO) United States $4.252B 0.00
TESARO (TSRO) United States $4.056B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.483B 12.90
FibroGen (FGEN) United States $3.361B 0.00
USANA Health Sciences (USNA) United States $2.895B 24.64
Endo (ENDP) Ireland $2.286B 3.50
Xencor (XNCR) United States $2.031B 0.00
Endocyte (ECYT) United States $1.957B 0.00
Heron Therapeutics (HRTX) United States $1.948B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.861B 251.44
Corcept Therapeutics (CORT) United States $1.860B 27.31
Ironwood Pharmaceuticals (IRWD) United States $1.810B 0.00
Zogenix (ZGNX) United States $1.739B 0.00
Aerie Pharmaceuticals (AERI) United States $1.737B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.697B 0.00
PTC Therapeutics (PTCT) United States $1.697B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.463B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.433B 20.15
Tricida (TCDA) United States $1.340B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.321B 0.00
Esperion Therapeutics (ESPR) United States $1.286B 0.00
Portola Pharmaceuticals (PTLA) United States $1.252B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.238B 0.00
TherapeuticsMD (TXMD) United States $0.921B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.906B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.807B 0.00
ImmunoGen (IMGN) United States $0.772B 0.00
Radius Health (RDUS) United States $0.719B 0.00
Forty Seven (FTSV) United States $0.712B 0.00
Collegium Pharmaceutical (COLL) United States $0.603B 0.00
Karyopharm Therapeutics (KPTI) United States $0.584B 0.00
Siga Technologies (SIGA) United States $0.558B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.513B 0.00
ChemoCentryx (CCXI) United States $0.507B 40.12
Flexion Therapeutics (FLXN) United States $0.505B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.455B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.446B 26.29
GlycoMimetics (GLYC) United States $0.446B 0.00
Akebia Therapeutics (AKBA) United States $0.435B 0.00
Xeris Pharmaceuticals (XERS) United States $0.420B 0.00
Dova Pharmaceuticals (DOVA) United States $0.418B 0.00
Dermira (DERM) United States $0.417B 0.00
Odonate Therapeutics (ODT) United States $0.406B 0.00
CASI Pharmaceuticals (CASI) United States $0.405B 0.00
Tyme Technologies (TYME) United States $0.398B 0.00
KalVista Pharmaceuticals (KALV) United States $0.390B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.373B 0.00
Translate Bio (TBIO) United States $0.370B 0.00
ArQule (ARQL) United States $0.351B 0.00
OptiNose (OPTN) United States $0.340B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.336B 0.00
Majesco Entertainment (PTE) United States $0.330B 0.00
Concert Pharmaceuticals (CNCE) United States $0.316B 0.00
Tapimmune (MRKR) United States $0.309B 0.00
Minerva Neurosciences (NERV) United States $0.305B 0.00
Aclaris Therapeutics (ACRS) United States $0.299B 0.00
Aratana Therapeutics (PETX) United States $0.299B 0.00
Mast Therapeutics (SVRA) United States $0.261B 0.00
Depomed (ASRT) United States $0.259B 9.64
Verrica Pharmaceuticals (VRCA) United States $0.258B 0.00
Aldeyra Therapeutics (ALDX) United States $0.248B 0.00
IMV INC (IMV) Canada $0.245B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.240B 0.00
Ocular Therapeutix (OCUL) United States $0.219B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.216B 0.00
Affimed (AFMD) Germany $0.213B 0.00
Galectin Therapeutics (GALT) United States $0.205B 0.00
Zafgen (ZFGN) United States $0.191B 0.00
Lannett Co Inc (LCI) United States $0.190B 1.65
TAIWAN LIPOSOME (TLC) Taiwan $0.188B 0.00
Aquestive Therapeutics (AQST) United States $0.184B 0.00
MEI Pharma (MEIP) United States $0.180B 0.00
Calithera Biosciences (CALA) United States $0.175B 0.00
Opexa Therapeutics (ACER) United States $0.174B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.172B 0.00
Molecular Templates (MTEM) United States $0.166B 0.00
ContraFect (CFRX) United States $0.165B 0.00
Recro Pharma (REPH) United States $0.164B 0.00
Nature's Sunshine Products (NATR) United States $0.162B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.159B 0.00
Neon Therapeutics (NTGN) United States $0.158B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.147B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.145B 0.00
Redhill Biopharma (RDHL) Israel $0.145B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.144B 0.00
Ardelyx (ARDX) United States $0.134B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.133B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.132B 0.00
MediWound (MDWD) Israel $0.130B 0.00
Cardiome Pharma (CORV) Canada $0.129B 0.00
ElectroCore (ECOR) United States $0.120B 0.00
Adherex Technologies (FENC) United States $0.117B 0.00
Jounce Therapeutics (JNCE) United States $0.115B 0.00
Rafael Holdings (RFL) United States $0.113B 0.00
DURECT (DRRX) United States $0.112B 0.00
Champions Oncology (CSBR) United States $0.110B 0.00
ProNAi Therapeutics (SRRA) Canada $0.104B 0.00
Iterum Therapeutics (ITRM) Ireland $0.102B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.093B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.091B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.086B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.081B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.081B 0.00
Immune Design (IMDZ) United States $0.076B 0.00
Achaogen (AKAO) United States $0.075B 0.00
Natural Alternatives (NAII) United States $0.075B 7.36
CTI BioPharma (CTIC) United States $0.072B 0.00
Otonomy (OTIC) United States $0.070B 0.00
Infinity Pharmaceuticals (INFI) United States $0.069B 0.00
Nivalis Therapeutics (ALPN) United States $0.066B 0.00
Melinta Therapeutics (MLNT) United States $0.066B 0.00
BioLineRx (BLRX) Israel $0.066B 0.00
Neos Therapeutics (NEOS) United States $0.062B 0.00
KemPharm (KMPH) United States $0.062B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.058B 36.31
Avenue Therapeutics (ATXI) United States $0.056B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.048B 0.00
Genocea Biosciences (GNCA) United States $0.048B 0.00
Mannatechorporated (MTEX) United States $0.045B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.043B 0.00
Forward Pharma (FWP) Denmark $0.042B 0.00
ProPhase Labs (PRPH) United States $0.036B 4.08
Capnia (SLNO) United States $0.035B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.034B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.033B 0.00
Novan (NOVN) United States $0.033B 0.00
Heat Biologics (HTBX) United States $0.030B 0.00
Lipocine (LPCN) United States $0.030B 0.00
IsoRay (ISR) United States $0.028B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.028B 0.00
Trillium Therapeutics (TRIL) Canada $0.027B 0.00
Can-Fite Biopharma (CANF) Israel $0.025B 0.00
Xenetic Biosciences (XBIO) United States $0.024B 0.00
SCYNEXIS (SCYX) United States $0.024B 0.00
Biomerica (BMRA) United States $0.023B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.023B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.021B 0.00
NanoViricides (NNVC) United States $0.021B 0.00
Jaguar Animal Health (JAGX) United States $0.020B 0.00
HANCOCK JAFFE (HJLI) United States $0.020B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.020B 0.00
Citius Pharmaceuticals (CTXR) United States $0.020B 0.00
PharmAthene (ALT) United States $0.019B 0.00
Aviragen Therapeutics (VXRT) United States $0.018B 0.00
Onconova Therapeutics (ONTX) United States $0.018B 0.00
Pain Therapeutics (PTIE) United States $0.018B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.017B 6.05
ESSA Pharma (EPIX) Canada $0.016B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.014B 0.00
Shineco (TYHT) China $0.013B 1.40
Regulus Therapeutics (RGLS) United States $0.012B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.010B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.010B 0.00
Skyline Medical (AIPT) United States $0.010B 0.00
Apricus Biosciences (APRI) United States $0.008B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.007B 0.00
Aradigm (ARDM) United States $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.006B 0.00
Midatech Pharma (MTP) United Kingdom $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.005B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.004B 0.00
Bio Blast Pharma (ORPN) Israel $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.003B 0.00
Intellipharmaceutics (IPCI) Canada $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
AGEX THERAPEUTC (AGE) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00